Willow Biosciences Inc. (CANSF)

Market Cap	3.76M
Revenue (ttm)	4.43M
Net Income (ttm)	-2.89M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	550,000
Average Volume	110,066
Open	0.0200
Previous Close	0.0240
Day's Range	0.0240 - 0.0300
52-Week Range	0.0027 - 0.1000
Beta	1.40
RSI	57.16
Earnings Date	Aug 11, 2025

About Willow Biosciences

Willow Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has licensing and development partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients and other ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2019
• Employees: 19
• Stock Exchange: OTCMKTS
• Ticker Symbol: CANSF

Financial Performance

In 2024, Willow Biosciences's revenue was 4.66 million, an increase of 297.78% compared to the previous year's 1.17 million. Losses were -6.19 million, -52.50% less than in 2023.

Financial numbers in CAD